Autologous Bone-Marrow Mesenchymal Stem Cell Implantation and Endothelial Function in a Rabbit Ischemic Limb Model

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Mikami, Shinsuke ^a   Nakashima, Ayumu ^b   Nakagawa, Keigo ^a   Maruhashi, Tatsuya ^a   Iwamoto, Yumiko ^a   Kajikawa, Masato ^a   Matsumoto, Takeshi ^a   Kihara, Yasuki ^a   Chayama, Kazuaki ^a   Noma, Kensuke ^b,c   Ochi, Mitsuo ^a   Nishimura, Masahiro ^d   Tsuji, Koichiro ^e   Kato, Yukio ^a   Goto, Chikara ^f   Higashi, Yukihito ^b,c  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e Two Cells Co Ltd Hiroshima   (Japan)

^f HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAPILLARY DENSITY; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; HISTOPATHOLOGY; LIMB BLOOD FLOW; LIMB ISCHEMIA; LIMB PERFUSION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE CAPILLARY; MUSCLE CELL; MUSCLE ISCHEMIA; NONHUMAN; RABBIT; THERAPY EFFECT; VASODILATATION;

ACETYLCHOLINE; ANIMALS; BONE MARROW CELLS; HEMODYNAMICS; HINDLIMB; ISCHEMIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; NITROARGININE; NITROPRUSSIDE; RABBITS; RECOVERY OF FUNCTION; TRANSPLANTATION, AUTOLOGOUS; VASODILATION; VASODILATOR AGENTS;

ORYCTOLAGUS CUNICULUS;

EID: 84879818960     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067739     Document Type: Article

References (39)

1. Gillum RF, (1990) Peripheral arterial occlusive disease of the extremities in the United States: hospitalization and mortality. Am Heart J 120: 1414-1418.
2. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, et al. (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326: 381-386.
3. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, et al. (2001) Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103: 897-95.
4. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, et al. (2002) Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Theraputic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet 360: 427-35.
5. Higashi Y, Kimura M, Hara K, Goto C, Noma K, et al. (2004) Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 109: 1215-1218.
6. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
7. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, et al. (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697-705.
8. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, et al. (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5: 309-313.
9. Deans RJ, Moseley AB, (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28: 875-884.
10. Iwase T, Nagaya N, Fujii T, Itoh T, Murakami S, et al. (2005) Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 66: 543-551.
11. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, et al. (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111: 150-156.
12. Furchgott RF, Zawadski JV, (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
13. Vallance P, Collier J, Moncada S, (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii: 997-1000.
14. Vanhoutte PM, (1989) Endothelium and control of vascular function. Hypertension 13: 658-667.
15. Lüscher TF, (1990) Imbalance of endothelium-derived relaxing and contracting factors. Am J Hypertens 3: 317-330.
16. Ross R, (1999) The pathogenesis of atherosclerosis. N Engl J Med 340: 115-126.
17. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, et al. (1997) Biochemical evidence for impaired nitric oxide synthase in patients with peripheral arterial occlusive disease. Circulation 95: 2068-74.
18. Rajagopalan S, Shah M, Luciano A, Crystal R, Nabel EG, (2001) Adenovirus-mediated gene transfer of VEGF121 improves lower-extremity endothelial function and flow reserve. Circulation 104: 753-755.
19. Santa Maria L, Rojas CV, Minguell JJ, (2004) Signals from damaged but not undamaged skeletal muscle induce myogenic differentiation of rat bone-marrow-derived mesenchymal stem cells. Exp Cell Res 300: 418-426.
20. Igarashi A, Segoshi K, Sakai Y, Pan H, Kanawa M, et al. (2007) Selection of Common Markers for Bone Marrow Stromal Cells from Various Bones Using Real-Time RT-PCR: Effects of Passage Number and Donor Age. Tissue Eng 13: 2405-2417.
21. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, et al. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843.
22. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC, (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75: 389-397.
23. Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, et al. (2006) Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81: 1589-1595.
24. Beggs KJ, Lyubimov A, Borneman JN, Bartholomew A, Moseley A, et al. (2006) Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant 15: 711-721.
25. Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, et al. (2004) Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33: 597-604.
26. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, et al. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441.
27. Miller VM, Vanhoutte PM, (1998) Enhanced release of endothelium-derived factors by chronic increases in blood flow. Am J Physiol 255: H446-H451.
28. Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, et al. (1995) Regulation of endothelial cell nitric oxide synthase m RNA expression by shear stress. Am J Physiol 269: C1371-C1378.
29. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze T, (1994) Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 74: 349-353.
30. Traub O, Berk BC, (1998) Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 18: 677-685.
31. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, et al. (1998) Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824.
32. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, et al. (1998) Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101: 40-50.
33. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, et al. (1995) Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 91: 2802-2809.
34. Shen B-Q, Lee DY, Zioncheck TZ, (1999) Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/FLK-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274: 33057-33063.
35. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, et al. (2002) Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 90: 866-873.
36. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, et al. (2004) Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94: 230-238.
37. O'Neill TJ 4th, Wamhoff BR, Owens GK, Skalak TC (2005) Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 97: 1027-1035.
38. Rehman J, Li J, Orschell CM, March KL, (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
39. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, et al. (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685.